| P2093 | author name string | Suwei Wang | |
| | Joy Joseph | |
| | Srigiridhar Kotamraju | |
| | B Kalyanaraman | |
| | Eugene A Konorev | |
| | Shasi Kalivendi | |
| P2860 | cites work | NF-kappaB prevents cells from undergoing Cr(VI)-induced apoptosis | Q23922085 |
| | Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 |
| | p53, the cellular gatekeeper for growth and division | Q27860990 |
| | Mitochondria and apoptosis | Q29547905 |
| | Caspases: killer proteases | Q29616315 |
| | p53: puzzle and paradigm | Q29618407 |
| | Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study | Q31419232 |
| | Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation. | Q33963311 |
| | ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3. | Q34155654 |
| | Signaling pathways activated by daunorubicin | Q34330164 |
| | Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors | Q34369172 |
| | bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis | Q36040551 |
| | Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines | Q37388228 |
| | Overexpression of manganese superoxide dismutase promotes survival in cell lines after doxorubicin treatment | Q40671365 |
| | A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy | Q40929887 |
| | Redox regulation of transcriptional activators | Q41150355 |
| | Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect TS-P53/K562 from apoptosis. | Q41283160 |
| | Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells | Q41477992 |
| | The p53 network | Q41673584 |
| | Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide | Q41817128 |
| | Early and delayed clinical cardiotoxicity of doxorubicin | Q42225832 |
| | Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappaB activity | Q42480361 |
| | A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. | Q43560472 |
| | GPx-1 gene delivery modulates NFkappaB activation following diverse environmental injuries through a specific subunit of the IKK complex | Q43699858 |
| | Reactivity of mono-meso-substituted iron(II) octaethylporphyrin complexes with hydrogen peroxide in the absence of dioxygen. Evidence for nucleophilic attack on the heme | Q43804813 |
| | Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. | Q43847020 |
| | Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species | Q43857544 |
| | The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart | Q44295644 |
| | Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. | Q46627102 |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| | apoptotic process | Q14599311 |
| P304 | page(s) | 25535-25543 | |
| P577 | publication date | 2004-03-30 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways | |
| P478 | volume | 279 | |